U.S. PHARMACEUTICAL SPRAY DRYING CDMO SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

The U.S. pharmaceutical spray drying CDMO services market is estimated to be valued at USD 790.2 Mn in 2025 and is expected to reach USD 1,345.5 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032. The U.S. pharmaceutical spray drying CDMO services market represents a critical segment within the broader pharmaceutical manufacturing industry, characterized by its sophisticated technology applications and essential role in drug formulation processes. Spray drying technology has emerged as a pivotal method for converting liquid pharmaceutical formulations into stable powder forms, enabling enhanced bioavailability, improved storage stability, and optimized drug delivery mechanisms.

This advanced manufacturing technique involves the transformation of liquid feed materials into dried particulate matter through rapid solvent evaporation in a controlled environment, making it indispensable for producing various pharmaceutical products including antibiotics, vaccines, probiotics, and complex drug compounds. The U.S. market has witnessed substantial growth driven by increasing demand for innovative drug delivery systems, rising prevalence of chronic diseases requiring specialized medications, and the pharmaceutical industry's continuous pursuit of enhanced manufacturing efficiency.

The technology's versatility in handling heat-sensitive materials while maintaining product integrity has positioned spray drying as a preferred choice among pharmaceutical manufacturers. Furthermore, the growing emphasis on personalized medicine and the development of novel therapeutic formulations have significantly contributed to the market's expansion, establishing spray drying as an integral component of modern pharmaceutical manufacturing processes across the United States.

Market Dynamics

The U.S. pharmaceutical spray drying CDMO services market is propelled by several key drivers that collectively fuel its robust growth trajectory, with the primary catalyst being the escalating demand for advanced drug delivery systems that enhance therapeutic efficacy and patient compliance, as pharmaceutical companies increasingly adopt spray drying technology to develop innovative formulations with improved bioavailability and controlled release properties.

The rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory ailments has intensified the need for specialized pharmaceutical products that benefit from spray drying processes, while the growing geriatric population requiring tailored medication formulations further amplifies market demand.

Additionally, stringent regulatory requirements mandating superior product quality and consistency have encouraged pharmaceutical manufacturers to invest in sophisticated spray drying equipment and technologies.

However, the market faces significant restraints including the substantial capital investment required for advanced spray drying equipment and infrastructure, which poses challenges particularly for small and medium-sized pharmaceutical companies with limited financial resources. Technical complexities associated with process optimization, parameter control, and the need for specialized expertise in operating spray drying systems create additional barriers to market entry and expansion.

Despite these challenges, the market presents numerous opportunities driven by the increasing focus on personalized medicine and precision therapeutics, which require customized formulation approaches that spray drying technology can effectively address. The growing trend toward biologics and biosimilar drug development creates substantial opportunities, as these complex molecules often benefit from spray drying for stabilization and improved shelf life.

Furthermore, emerging applications in nanotechnology-based drug delivery systems and the development of novel excipients specifically designed for spray drying processes offer significant growth potential for market participants willing to invest in research and development initiatives.

Key Features of the Study

• This report provides in-depth analysis of the U.S. pharmaceutical spray drying CDMO services market , and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S. pharmaceutical spray drying CDMO services market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Advanced Powder Dynamics, Serán Bioscience, LLC, Agraform, Altasciences, Bend Bioscience, Catalent, Inc, CritiTech, Elise Biopharma, Fuji Chemical Industries USA, Inc, Hovione, Lonza, PACE, Pharma Spray Drying, Inc, Quotient Sciences, Richman Chemical Inc, Spray-Tek, Thermo Fisher Scientific Inc (Patheon), WuXi STA, Codis, and Other Prominent Players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The U.S. pharmaceutical spray drying CDMO services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. pharmaceutical spray drying CDMO services market

Market Segmentation

• Service Offerings Insights (Revenue, USD Mn, 2020 - 2032)
  • Standard Spray Drying Services
  • Formulation Development + Spray Drying
  • Spray Dried Dispersion (SDD) Services
  • Others Services (Scale Up & Tech Transfer & Others)
• Product Insights (Revenue, USD Mn, 2020 - 2032)
  • Small Molecules and APIs
  • High Potent Active Pharmaceutical Ingredients (HPAPI)
  • Excipients
  • Co-Spray Drying/Composite Particle Formation (API + Excipient)
  • Controlled Substances
  • Biologics/Proteins/Peptide
  • Others (Nutraceutical/Dietary Supplement Powders and Others)
• Operational Scale Insights (Revenue, USD Mn, 2020 - 2032)
  • Pilot/Clinical-Scale Services
  • Commercial/Industrial-Scale Services
• Application Area Insights (Revenue, USD Mn, 2020 - 2032)
  • Oral Dosage Forms (powders, granules, or ASD for tablets/capsules)
  • Injectable/Parenteral (intermediate powders for reconstitution)
  • Pulmonary/Inhalation Delivery (dry powders for inhalers)
  • Encapsulated Formulations/Co-Spray Dried Particles
  • Others (Controlled Release/Sustained Release and Others)
• End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Pharmaceutical Companies
  • Biopharmaceutical/Biotechnology Companies
  • Academic or Contract Research Organizations (CROs)
  • Others (Nutraceutical and Dietary Supplement Companies and Others)
• Key Players Insights
  • Advanced Powder Dynamics
  • Serán Bioscience, LLC
  • Agraform
  • Altasciences
  • Bend Bioscience
  • Catalent, Inc
  • CritiTech
  • Elise Biopharma
  • Fuji Chemical Industries USA, Inc
  • Hovione
  • Lonza
  • PACE
  • Pharma Spray Drying, Inc
  • Quotient Sciences
  • Richman Chemical Inc
  • Spray-Tek
  • Thermo Fisher Scientific Inc (Patheon)
  • WuXi STA
  • Codis
  • Other Prominent Players